AVADEL PHARMACEUTICALS PLC

Nasdaq:AVDL

Pharmaceutical Preparations·DUBLIN 2

Avadel Pharmaceuticals plc was an Irish specialty pharmaceutical company focused on sleep disorder medicines marketed for hospital and primary care treatments. Headquartered in Dublin, Ireland, it had operations in St.

CFO

Mchugh Thomas S

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	8/7/25	→
10-Q	Q1 2025	3/31/25	5/7/25	→
10-K	FY 2024	12/31/24	3/3/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/8/24	→
↓

Earnings Releases (8-K)

19 shown

Filed	Period
11/4/25	Q4 FY2025	→
8/7/25	Q3 FY2025	→
5/7/25	Q2 FY2025	→
3/3/25	Q1 FY2025	→
1/8/25	Q4 FY2025	→
11/12/24	Q4 FY2024	→
↓

News (8-K)

61 shown

Filed	Type	Description
2/12/26	Delisting	Termination of a Material Definitive Agreement	→
1/20/26	Other	Other Events	→
1/12/26	Vote	Submission of Matters to a Vote of Security Holders	→
12/18/25	Reg FD	Regulation FD Disclosure	→
12/9/25	Other	Other Events	→
11/19/25	Agreement	Entry into a Material Definitive Agreement	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
2/12/26	S-8 POS	S-8 POS	→
2/12/26	S-8 POS	S-8 POS	→
2/12/26	S-8 POS	S-8 POS	→
2/12/26	S-8 POS	S-8 POS	→
2/12/26	S-8 POS	S-8 POS	→
2/12/26	S-8 POS	S-8 POS	→
↓

Filing History(1000 filings)

TypeDateAccessionPeriodSize

15-12G

Feb 23, 2026

0001104659-26-01828215-12G

—

12.8 KB

Feb 18, 2026

0001357550-26-000015PRIMARY DOCUMENT

Feb 13, 2026

7.4 KB

Feb 18, 2026

0001357550-26-000014PRIMARY DOCUMENT

Feb 11, 2026

5.9 KB

SCHEDULE 13G/A

Feb 17, 2026

0001011438-26-000152

—

10.1 KB

SCHEDULE 13G/A

Feb 17, 2026

0001274173-26-000063

—

11.8 KB

EFFECT

Feb 13, 2026

9999999995-26-000566

—

1.8 KB

EFFECT

Feb 13, 2026

9999999995-26-000565

—

1.8 KB

EFFECT

Feb 13, 2026

9999999995-26-000564

—

1.8 KB

EFFECT

Feb 13, 2026

9999999995-26-000563

—

1.8 KB

Feb 12, 2026

0001104659-26-014449OWNERSHIP DOCUMENT

Feb 12, 2026

7.0 KB

Feb 12, 2026

0001104659-26-014448OWNERSHIP DOCUMENT

Feb 12, 2026

22.2 KB

Feb 12, 2026

0001104659-26-014447OWNERSHIP DOCUMENT

Feb 12, 2026

22.1 KB

Feb 12, 2026

0001104659-26-014446OWNERSHIP DOCUMENT

Feb 12, 2026

25.5 KB

Feb 12, 2026

0001104659-26-014445OWNERSHIP DOCUMENT

Feb 12, 2026

19.9 KB

Feb 12, 2026

0001104659-26-014444OWNERSHIP DOCUMENT

Feb 12, 2026

26.2 KB

Feb 12, 2026

0001104659-26-014443OWNERSHIP DOCUMENT

Feb 12, 2026

27.1 KB

Feb 12, 2026

0001104659-26-014442OWNERSHIP DOCUMENT

Feb 12, 2026

24.2 KB

Feb 12, 2026

0001104659-26-014441OWNERSHIP DOCUMENT

Feb 12, 2026

30.5 KB

Feb 12, 2026

0001104659-26-014438OWNERSHIP DOCUMENT

Feb 12, 2026

13.5 KB

S-8 POS

Feb 12, 2026

0001104659-26-014398S-8 POS

—

35.8 KB

S-8 POS

Feb 12, 2026

0001104659-26-014397S-8 POS

—

35.8 KB

S-8 POS

Feb 12, 2026

0001104659-26-014394S-8 POS

—

35.8 KB

S-8 POS

Feb 12, 2026

0001104659-26-014393S-8 POS

—

35.8 KB

S-8 POS

Feb 12, 2026

0001104659-26-014391S-8 POS

—

35.8 KB

S-8 POS

Feb 12, 2026

0001104659-26-014389S-8 POS

—

35.8 KB

25 filings shown

Filed	Form	Description
12/19/25	DEFA14A	DEFA14A	→
12/9/25	DEFA14A	DEFA14A	→
12/3/25	DEFM14A	DEFM14A	→
11/19/25	DEFA14A	DEFA14A	→
11/19/25	DEFA14A	DEFA14A	→
11/17/25	DEFA14A	DEFA14A	→
↓

AVADEL PHARMACEUTICALS PLC

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(1000 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/18/26	4	PRIMARY DOCUMENT	→
2/18/26	3	PRIMARY DOCUMENT	→
2/12/26	4	OWNERSHIP DOCUMENT	→
2/12/26	4	OWNERSHIP DOCUMENT	→
2/12/26	4	OWNERSHIP DOCUMENT	→
2/12/26	4	OWNERSHIP DOCUMENT	→
↓

Filed	Form	Description
2/23/26	15-12G	15-12G	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/13/26	EFFECT	EFFECT	→
2/13/26	EFFECT	EFFECT	→
2/13/26	EFFECT	EFFECT	→
↓